Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neural Transmission (Vienna, Austria : 1996)|May 5, 2023
Parkinson's disease therapy: what lies ahead?Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, et al.
European Journal of Neurology|May 9, 2023
Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinicJakub Scaber, Alexander G Thompson, Lucy Farrimond, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 17, 2014
Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseasesEmily Feneberg, Petra Steinacker, Stefan Lehnert, et al.
Brain Communications|October 23, 2024
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neuronsRuxandra Dafinca, Carlota Tosat-Bitrian, Emily Carroll, et al.
European Journal of Neurology|November 19, 2024
Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort studyAli Maisam Afzali, Milan Vosko, Nya Reinhardt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 15, 2015
Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLDEmily Feneberg, Petra Steinacker, Alexander Erich Volk, et al.
Plos One|January 29, 2026
Retrospective analysis of neurofilament-light chain in patients with inflammatory bowel disease - A pilot studyAndreas Wolff, Emily Feneberg, Julius Shakhtour, et al.
Journal of Proteome Research|August 6, 2014
Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degenerationPatrick Oeckl, Petra Steinacker, Christine A F von Arnim, et al.
Brain Pathology (Zurich, Switzerland)|December 10, 2020
Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDPEmily Feneberg, Philip D Charles, Mattéa J Finelli, et al.
Frontiers in Cellular Neuroscience|April 6, 2026
Serum NfL and GFAP in post-COVID syndrome: minimal evidence of CNS injury after adjusting for confoundersMichael Wunderle, Andrea Ribeiro, Isabelle Lethen, et al.
Pageof 4